Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1997;81:154-164

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Decking, U. K. M.
Right arrow Articles by Schrader, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Decking, U. K. M.
Right arrow Articles by Schrader, J.
(Circulation Research. 1997;81:154-164.)
© 1997 American Heart Association, Inc.


Articles

Hypoxia-Induced Inhibition of Adenosine Kinase Potentiates Cardiac Adenosine Release

Ulrich K. M. Decking, Georg Schlieper, Keith Kroll, , Jürgen Schrader

From the Institut für Herz und Kreislaufphysiologie (U.K.M.D., G.S., J.S.), Heinrich-Heine-Universität Düsseldorf (Germany), and the Center for Bioengineering (K.K.), University of Washington, Seattle.

Correspondence to Ulrich Decking, MD, Department of Physiology, Heinrich-Heine-University Düsseldorf, PO Box 10 10 07, 40001 Düsseldorf, Germany. E-mail ulrich.decking{at}uni-duesseldorf.de

Abstract To elucidate the physiological role of the AMP-adenosine metabolic cycle and to investigate the relation between AMP and adenosine formation, the O2 supply of isolated guinea pig hearts was varied (95% to 10% O2). The net adenosine formation rate (AMP->adenosine) and coronary venous effluent adenosine release rate were measured; free cytosolic AMP was determined by 31P-nuclear magnetic resonance. Switching from 95% to 40% O2 increased free AMP and adenosine formation 4-fold, whereas free cytosolic adenosine and venous adenosine release rose 15- to 20-fold. In the AMP range from 200 to 3000 nmol/L, there was a linear correlation between free AMP and adenosine formation (R2=.71); however, adenosine release increased several-fold more than formation. At 95% O2, only 6% of the adenosine formed was released; however, this fraction increased to 22% at 40% O2, demonstrating reduced adenosine salvage. Selective blockade of adenosine deaminase and adenosine kinase indicated that flux through adenosine kinase decreased from 85% to 35% of adenosine formation in hypoxia. Mathematical model analysis indicated that this apparent decrease in enzyme activity was not due to saturation but to the inhibition of adenosine kinase activity to 6% of the basal levels. The data show (1) that adenosine formation is proportional to the AMP substrate concentration and (2) that hypoxia decreases adenosine kinase activity, thereby shunting myocardial adenosine from the salvage pathway to venous release. In conclusion, because of the normal high turnover of the AMP-adenosine metabolic cycle, hypoxia-induced inhibition of adenosine kinase causes the amplification of small changes in free AMP into a major rise in adenosine. This mechanism plays an important role in the high sensitivity of the cardiac adenosine system to impaired oxygenation.


Key Words: adenosine • adenosine kinase • hypoxia • 31P nuclear magnetic resonance spectroscopy




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Ohta, A. Ohta, M. Madasu, R. Kini, M. Subramanian, N. Goel, and M. Sitkovsky
A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
J. Immunol., November 1, 2009; 183(9): 5487 - 5493.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Nakav, O. Naamani, C. Chaimovitz, G. Shaked, D. Czeiger, M. Zlotnik, and A. Douvdevani
Regulation of adenosine system at the onset of peritonitis
Nephrol. Dial. Transplant., October 26, 2009; (2009) gfp542v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Hatfield, B. Belikoff, D. Lukashev, M. Sitkovsky, and A. Ohta
The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells
J. Leukoc. Biol., September 1, 2009; 86(3): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-S. Frick, C. F. MacManus, M. Scully, L. E. Glover, H. K. Eltzschig, and S. P. Colgan
Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis
J. Immunol., April 15, 2009; 182(8): 4957 - 4964.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. V. Sitkovsky, J. Kjaergaard, D. Lukashev, and A. Ohta
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Clin. Cancer Res., October 1, 2008; 14(19): 5947 - 5952.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. V. Sitkovsky
Damage control by hypoxia-inhibited AK
Blood, June 15, 2008; 111(12): 5424 - 5425.
[Full Text] [PDF]


Home page
BloodHome page
J. C. Morote-Garcia, P. Rosenberger, J. Kuhlicke, and H. K. Eltzschig
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Blood, June 15, 2008; 111(12): 5571 - 5580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ohta, D. Lukashev, E. K. Jackson, B. B. Fredholm, and M. Sitkovsky
1,3,7-Trimethylxanthine (Caffeine) May Exacerbate Acute Inflammatory Liver Injury by Weakening the Physiological Immunosuppressive Mechanism
J. Immunol., December 1, 2007; 179(11): 7431 - 7438.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. P. Dzeja, P. Bast, D. Pucar, B. Wieringa, and A. Terzic
Defective Metabolic Signaling in Adenylate Kinase AK1 Gene Knock-out Hearts Compromises Post-ischemic Coronary Reflow
J. Biol. Chem., October 26, 2007; 282(43): 31366 - 31372.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. C. Caldwell, J. Tschoep, and A. B. Lentsch
Lymphocyte function during hepatic ischemia/reperfusion injury
J. Leukoc. Biol., September 1, 2007; 82(3): 457 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein
Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages
J. Immunol., May 1, 2007; 178(9): 5921 - 5929.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. Kong, K. A. Westerman, M. Faigle, H. K. Eltzschig, and S. P. Colgan
HIF-dependent induction of adenosine A2B receptor in hypoxia
FASEB J, November 1, 2006; 20(13): 2242 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay
Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C433 - C444.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Barnes, H. Dobrzynski, S. Foppolo, P. R. Beal, F. Ismat, E. R. Scullion, L. Sun, J. Tellez, M. W.L. Ritzel, W. C. Claycomb, et al.
Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH
Circ. Res., September 1, 2006; 99(5): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Ohta, E. Gorelik, S. J. Prasad, F. Ronchese, D. Lukashev, M. K. K. Wong, X. Huang, S. Caldwell, K. Liu, P. Smith, et al.
A2A adenosine receptor protects tumors from antitumor T cells
PNAS, August 29, 2006; 103(35): 13132 - 13137.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. Vallon, B. Muhlbauer, and H. Osswald
Adenosine and kidney function.
Physiol Rev, July 1, 2006; 86(3): 901 - 940.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Willems, M. E. Reichelt, J. G. Molina, C.-X. Sun, J. L. Chunn, K. J. Ashton, J. Schnermann, M. R. Blackburn, and J. P. Headrick
Effects of adenosine deaminase and A1 receptor deficiency in normoxic and ischaemic mouse hearts
Cardiovasc Res, July 1, 2006; 71(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. K. Eltzschig, P. Abdulla, E. Hoffman, K. E. Hamilton, D. Daniels, C. Schonfeld, M. Loffler, G. Reyes, M. Duszenko, J. Karhausen, et al.
HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia
J. Exp. Med., December 5, 2005; 202(11): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. H. Adair
Growth regulation of the vascular system: an emerging role for adenosine
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Gallos, T. D. Ruyle, C. W. Emala, and H. T. Lee
A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F369 - F376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S J. James, P. Cutler, S. Melnyk, S. Jernigan, L. Janak, D. W Gaylor, and J. A Neubrander
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1611 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Olsson
Cardiovascular Ecto-5'-Nucleotidase: An End to 40 Years in the Wilderness?
Circ. Res., October 15, 2004; 95(8): 752 - 753.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P. Koszalka, B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel, N. Braun, A. Buchheiser, U. K.M. Decking, M. L. Smith, J. Sevigny, et al.
Targeted Disruption of cd73/Ecto-5'-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response
Circ. Res., October 15, 2004; 95(8): 814 - 821.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Chaudary, Z. Naydenova, I. Shuralyova, and I. R. Coe
The Adenosine Transporter, mENT1, Is a Target for Adenosine Receptor Signaling and Protein Kinase C{epsilon} in Hypoxic and Pharmacological Preconditioning in the Mouse Cardiomyocyte Cell Line, HL-1
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Zhang, D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin
Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases
J. Immunol., July 15, 2004; 173(2): 932 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lukashev, A. Ohta, S. Apasov, J.-F. Chen, and M. Sitkovsky
Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo
J. Immunol., July 1, 2004; 173(1): 21 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Y. Tan, M. Mujoomdar, and J. Blay
Adenosine Down-Regulates the Surface Expression of Dipeptidyl Peptidase IV on HT-29 Human Colorectal Carcinoma Cells: Implications for Cancer Cell Behavior
Am. J. Pathol., July 1, 2004; 165(1): 319 - 330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Inbe, S. Watanabe, M. Miyawaki, E. Tanabe, and J. A. Encinas
Identification and Characterization of a Cell-Surface Receptor, P2Y15, for AMP and Adenosine
J. Biol. Chem., May 7, 2004; 279(19): 19790 - 19799.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. B Blood, C. J Hunter, and G. G Power
Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep
J. Physiol., December 15, 2003; 553(3): 935 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, Z. Mi, C. Zhu, and R. K. Dubey
Adenosine Biosynthesis in the Collecting Duct
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 888 - 896.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Lu, A. Pierron, and K. Ravid
An Adenosine Analogue, IB-MECA, Down-Regulates Estrogen Receptor {alpha} and Suppresses Human Breast Cancer Cell Proliferation
Cancer Res., October 1, 2003; 63(19): 6413 - 6423.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Mubagwa and W. Flameng
Adenosine, adenosine receptors and myocardial protection: An updated overview
Cardiovasc Res, October 1, 2001; 52(1): 25 - 39.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. K.M. Decking, J. P. Williams, R. Dahmann, T. Stumpe, M. Kelm, and J. Schrader
The nitric oxide-induced reduction in cardiac energy supply is not due to inhibition of creatine kinase
Cardiovasc Res, August 1, 2001; 51(2): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Nishiyama, S. Kimura, H. He, K. Miura, M. Rahman, Y. Fujisawa, T. Fukui, and Y. Abe
Renal interstitial adenosine metabolism during ischemia in dogs
Am J Physiol Renal Physiol, February 1, 2001; 280(2): F231 - F238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-W. Gu, B. R. Ito, A. Sartin, N. Frascogna, M. Moore, and T. H. Adair
Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2116 - H2123.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. A. Rosenberg, Y. Li, M. Le, and Y. Zhang
Nitric Oxide-Stimulated Increase in Extracellular Adenosine Accumulation in Rat Forebrain Neurons in Culture Is Associated with ATP Hydrolysis and Inhibition of Adenosine Kinase Activity
J. Neurosci., August 15, 2000; 20(16): 6294 - 6301.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. F. Pauly and C. J. Pepine
D-Ribose as a Supplement for Cardiac Energy Metabolism
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 249 - 258.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
L. A Gustafson, C. J Zuurbier, J. E Bassett, J. P. F Barends, J. H.G.M van Beek, J. B Bassingthwaighte, and K. Kroll
Increased hypoxic stress decreases AMP hydrolysis in rabbit heart
Cardiovasc Res, November 1, 1999; 44(2): 333 - 343.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Winegrad, D. Henrion, L. Rappaport, and J. L. Samuel
Self-Protection by Cardiac Myocytes Against Hypoxia and Hyperoxia
Circ. Res., October 15, 1999; 85(8): 690 - 698.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Costa, P. Sulur, M. Angel, J. Cavalcante, V. Haile, B. Christman, and I. Biaggioni
Intravascular Source of Adenosine During Forearm Ischemia in Humans : Implications for Reactive Hyperemia
Hypertension, June 1, 1999; 33(6): 1453 - 1457.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. P. Dzeja and A. Terzic
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels
FASEB J, May 1, 1998; 12(7): 523 - 529.
[Abstract] [Full Text]


Home page
JGPHome page
A. E. Alekseev, P. A. Brady, and A. Terzic
Ligand-insensitive State of Cardiac ATP-sensitive K+ Channels: Basis for Channel Opening
J. Gen. Physiol., February 1, 1998; 111(2): 381 - 394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. A. Gustafson and K. Kroll
Downregulation of 5'-nucleotidase in rabbit heart during coronary underperfusion
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H529 - H538.
[Abstract] [Full Text] [PDF]